• Antibodies to HHV-6 during acute COVID-19 may help predict development of Long COVID

    Autoantibodies directed against neural targets have most predictive power.

  • iciHHV-6B linked to systemic lupus erythematosus (SLE) in Japanese and European populations

    iciHHV-6B, when integrated into chromosome 22q, was strongly associated with SLE and with SLE severity.

  • HHV-6 linked to miscarriage through Mendelian randomization studies

    The findings are consistent with previous studies directly linking HHV-6 endometrial infection to miscarriage.

  • Finnish investigators find unexpected evidence of HHV-6B integration into mitochondrial DNA

    Could HHV-6B infection exacerbate mitochondrial disease?

Newsletter | About Us | Contact Us | Donate | Repository

HHV-6 Foundation | HHV-6 Disease Information for Patients, Clinicians, and Researchers | Apply for a Grant Navigation
  • Home
  • About
    • Scientific Advisory Board
    • Staff
    • Contact Us
    • Donate
  • Patients
    • What Is HHV-6?
    • HHV-6A/B Testing
  • Research
    • Grants
    • Repository
      • Cart
      • Checkout
    • HHV-6A/B Testing
    • List of Genes & Proteins
    • Lab Protocols
    • Pictorial Atlas of HHV-6
    • HHV-6 Antivirals
    • Researcher FAQ
    • Newsletter
  • Home
  • About
    • Scientific Advisory Board
    • Staff
    • Contact Us
    • Donate
  • Patients
    • What Is HHV-6?
    • HHV-6A/B Testing
  • Research
    • Grants
    • Repository
      • Cart
      • Checkout
    • HHV-6A/B Testing
    • List of Genes & Proteins
    • Lab Protocols
    • Pictorial Atlas of HHV-6
    • HHV-6 Antivirals
    • Researcher FAQ
    • Newsletter

Latest HHV-6 Research Articles

View Post

German HCT specialists call for iciHHV-6 screening of patients and donors

In All, ciHHV-6, Transplant Complications by Kristin LoomisMarch 30, 2023

Study finds value in HHV-6 testing of other tissues, as well as blood, and of routine testing for iciHHV-6 in both donors and recipients of allo-HCT.

View Post

Stanford WGS study: Widespread integration and reactivation of HHV-6B and HHV-7 in lymphoblastoid cells immortalized with EBV

In All, Heart Disease by Kristin LoomisMarch 30, 2023

EBV infected B cells may represent a site of HHV-6 latency.

View Post

Individuals seropositive for herpesviruses may have greater risk of dementia

In All, Alzheimer's Disease, CNS Disease, Encephalitis & Encephalopathy by Kristin LoomisFebruary 20, 2023

Large study from UK Biobank finds that people seropositive for all of these four herpesviruses—HSV-1, HHV-6, HHV-7 and VZV—have greatly increased risk of developing dementia.

View Post

Parvovirus B19 and HHV-6 in biopsies of South African patients with acute myocarditis

In All, Heart Disease by Kristin LoomisFebruary 20, 2023

Parvovirus B19 was the most common virus found, followed by EBV and HHV-6.

View Post

Coronary artery spasm often occurs in myocarditis cases with biopsy-proven HHV-6 and parvovirus B19 infection

In All, Heart Disease by Kristin LoomisFebruary 20, 2023

Both viruses were associated with large vessel spasm, but parvovirus B19 was also associated with microvascular spasm.

View Post

Evidence for viral myocarditis in 2.3% of infant sudden death cases

In All, Heart Disease by Kristin LoomisFebruary 20, 2023

Enteroviruses and parvovirus B19 were found more frequently than HHV-6.

View Post

Fatal myocarditis from HHV-6 in immunocompetent adult suspected of COVID-19

In All, COVID-19 / HHV-6 Reactivation, Heart Disease by Kristin LoomisFebruary 20, 2023

Case report does not distinguish HHV-6A from HHV-6B nor possible role of virus in other organ pathology.

View Post

Differentially expressed HHV-6A/B and HHV-7 genes may have prognostic value in gliomas

In All, Cancer, Genes by Kristin LoomisFebruary 20, 2023

Unclear if viral gene expression signature confers prognostic information that is independent of host cell gene expression signatures.

View Post

Herpesvirus reactivation during alloHSCT associated with greatly increased mortality and expense

In All, CNS Disease, Transplant Complications by Kristin LoomisJanuary 9, 2023

Data from 13,363 transplant patients underline the importance of preventing, diagnosing and treating viral reactivation.

View Post

Another report links HHV-6B nucleic acid and antigen to mesial temporal lobe epilepsy

In All, CNS Disease, Epilepsy and Seizures by Kristin LoomisJanuary 9, 2023

Viral DNA and antigen found at higher levels in MTLE than in control brains.

View Post

HHV-6 DNA often found in cerebrospinal fluid in samples tested for meningitis

In All, CNS Disease, Encephalitis & Encephalopathy by Kristin LoomisJanuary 9, 2023

Those with viral infections showed no difference in white or red blood cell counts or the protein and glucose levels.

View Post

Artesunate compares favorably to herpesvirus antivirals in suppressing HHV-6 and HHV-7

In All, Treatments - Alternative, Treatments - Antiviral by Kristin LoomisJanuary 9, 2023

Non-randomized study finds somewhat more potent reduction of virus in leucocytes over several months of treatment.

View Post

Virus specific T cell infusions show promise for preventing HHV-6B reactivation in transplant patients

In All, Transplant Complications, Treatments - Adoptive T cell, Treatments - Alternative by Kristin LoomisJanuary 9, 2023

Review highlights the importance of cell mediated immunity and the limitations of antivirals, vaccines and immunoglobulin therapy for HHV-6, VZV and HSV.

View Post

HHV-6 found in postmortem study of myalgic encephalomyelitis/chronic fatigue syndrome

In All, CNS Disease, ME/CFS by Kristin LoomisJanuary 9, 2023

Because of small number of ME/CFS subjects, the study is provocative rather than conclusive.

View Post

Increased HHV-6B viral load and levels of autonomic autoantibodies in ME/CFS

In All, Autoimmune Disease, CNS Disease, ME/CFS by Kristin LoomisJanuary 9, 2023

Biomarkers distinguish cases from healthy controls, but don’t all correlate with disease severity.

  • Page 8 of 38
  • ←
  • 1
  • ...
  • 7
  • 8
  • 9
  • ...
  • 38
  • →

Clinical News

  • Alzheimer’s Disease
  • Animal Models
  • Autoimmune Disease
  • Cancer
  • iciHHV-6
  • CNS Disease
  • COVID-19 / HHV-6 Reactivation
  • Drug Hypersensitivity
  • Encephalitis & Encephalopathy
  • Endocrine Conditions
  • Epilepsy and Seizures
  • Gastrointestinal
  • Genes
  • Heart Disease
  • Hematological Disorders
  • HIV/AIDS Progression
  • Immunity & Immunotherapy
  • Infertility & Miscarriage
  • Kidney Disease
  • Liver Disease
  • Lung Disease
  • Lymphadenopathy & Fever
  • ME/CFS
  • Multiple Sclerosis
  • Rash & Roseola
  • Transplant Complications
  • Treatments – Adoptive T cell
  • Treatments – Alternative
  • Treatments – Antiviral
  • Treatments – Immune Stimulant

About HHV-6

  • What Is HHV-6?
  • What is Inherited Chromosomally Integrated HHV-6
  • HHV-6 Repository of Reagents
  • HHV-6A/B Testing
  • HHV-6 Treatment

SUBSCRIBE TO OUR NEWSLETTER

ABOUT THE HHV-6 FOUNDATION

The HHV-6 Foundation in a non-profit entity founded to encourage scientific exchange between investigators and to provide pilot grants for promising scientific and clinical research on the under- appreciated viruses HHV-6A and HHV-6B.

The Foundation sponsors international conferences and supports scientists and clinicians seeking to clarify the role of the two HHV-6 viruses in disease. Since HHV-6A and HHV-6B can smolder in the brain and other organs without circulating in the peripheral blood or plasma, identifying chronic infection is a challenge.

Read More

HHV-6 Foundation | 1482 East Valley Road, Suite 619 | Santa Barbara, CA, 93108 | Toll Free: (888) 530-6726


Copyright ©2004-2022 HHV-6 FOUNDATION


WEB DESIGN AND DEVELOPMENT BY INSTYLE TECHNOLOGIES
  • Home
  • About
  • Conditions
  • Clinicians
  • Testing
  • Research
  • Repository
  • Patients
  • Treatment
  • News & Blog
  • Donate
  • Contact Us
  • Cart
  • Checkout
  • Privacy Policy
  • Terms of Use